These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

500 related items for PubMed ID: 16813529

  • 1. Disease status in autosomal dominant osteopetrosis type 2 is determined by osteoclastic properties.
    Chu K, Snyder R, Econs MJ.
    J Bone Miner Res; 2006 Jul; 21(7):1089-97. PubMed ID: 16813529
    [Abstract] [Full Text] [Related]

  • 2. In vitro differentiation of CD14 cells from osteopetrotic subjects: contrasting phenotypes with TCIRG1, CLCN7, and attachment defects.
    Blair HC, Borysenko CW, Villa A, Schlesinger PH, Kalla SE, Yaroslavskiy BB, Garćia-Palacios V, Oakley JI, Orchard PJ.
    J Bone Miner Res; 2004 Aug; 19(8):1329-38. PubMed ID: 15231021
    [Abstract] [Full Text] [Related]

  • 3. Limited rescue of osteoclast-poor osteopetrosis after successful engraftment by cord blood from an unrelated donor.
    Nicholls BM, Bredius RG, Hamdy NA, Gerritsen EJ, Lankester AC, Hogendoorn PC, Nesbitt SA, Horton MA, Flanagan AM.
    J Bone Miner Res; 2005 Dec; 20(12):2264-70. PubMed ID: 16294279
    [Abstract] [Full Text] [Related]

  • 4. Osteoclast-derived serum tartrate-resistant acid phosphatase 5b in Albers-Schonberg disease (type II autosomal dominant osteopetrosis).
    Alatalo SL, Ivaska KK, Waguespack SG, Econs MJ, Väänänen HK, Halleen JM.
    Clin Chem; 2004 May; 50(5):883-90. PubMed ID: 15016726
    [Abstract] [Full Text] [Related]

  • 5. RANKL coordinates cell cycle withdrawal and differentiation in osteoclasts through the cyclin-dependent kinase inhibitors p27KIP1 and p21CIP1.
    Sankar U, Patel K, Rosol TJ, Ostrowski MC.
    J Bone Miner Res; 2004 Aug; 19(8):1339-48. PubMed ID: 15231022
    [Abstract] [Full Text] [Related]

  • 6. Critical role of beta3 integrin in experimental postmenopausal osteoporosis.
    Zhao H, Kitaura H, Sands MS, Ross FP, Teitelbaum SL, Novack DV.
    J Bone Miner Res; 2005 Dec; 20(12):2116-23. PubMed ID: 16294265
    [Abstract] [Full Text] [Related]

  • 7. Estrogen and testosterone use different cellular pathways to inhibit osteoclastogenesis and bone resorption.
    Michael H, Härkönen PL, Väänänen HK, Hentunen TA.
    J Bone Miner Res; 2005 Dec; 20(12):2224-32. PubMed ID: 16294275
    [Abstract] [Full Text] [Related]

  • 8. Macrophage colony-stimulating factor and receptor activator NF-kappaB ligand fail to rescue osteoclast-poor human malignant infantile osteopetrosis in vitro.
    Flanagan AM, Massey HM, Wilson C, Vellodi A, Horton MA, Steward CG.
    Bone; 2002 Jan; 30(1):85-90. PubMed ID: 11792569
    [Abstract] [Full Text] [Related]

  • 9. Isolation of human osteoclasts formed in vitro: hormonal effects on the bone-resorbing activity of human osteoclasts.
    Kudo O, Sabokbar A, Pocock A, Itonaga I, Athanasou NA.
    Calcif Tissue Int; 2002 Dec; 71(6):539-46. PubMed ID: 12232680
    [Abstract] [Full Text] [Related]

  • 10. A new heterozygous mutation (R714C) of the osteopetrosis gene, pleckstrin homolog domain containing family M (with run domain) member 1 (PLEKHM1), impairs vesicular acidification and increases TRACP secretion in osteoclasts.
    Del Fattore A, Fornari R, Van Wesenbeeck L, de Freitas F, Timmermans JP, Peruzzi B, Cappariello A, Rucci N, Spera G, Helfrich MH, Van Hul W, Migliaccio S, Teti A.
    J Bone Miner Res; 2008 Mar; 23(3):380-91. PubMed ID: 17997709
    [Abstract] [Full Text] [Related]

  • 11. Osteoclasts from patients with autosomal dominant osteopetrosis type I caused by a T253I mutation in low-density lipoprotein receptor-related protein 5 are normal in vitro, but have decreased resorption capacity in vivo.
    Henriksen K, Gram J, Høegh-Andersen P, Jemtland R, Ueland T, Dziegiel MH, Schaller S, Bollerslev J, Karsdal MA.
    Am J Pathol; 2005 Nov; 167(5):1341-8. PubMed ID: 16251418
    [Abstract] [Full Text] [Related]

  • 12. Human osteoclast-poor osteopetrosis with hypogammaglobulinemia due to TNFRSF11A (RANK) mutations.
    Guerrini MM, Sobacchi C, Cassani B, Abinun M, Kilic SS, Pangrazio A, Moratto D, Mazzolari E, Clayton-Smith J, Orchard P, Coxon FP, Helfrich MH, Crockett JC, Mellis D, Vellodi A, Tezcan I, Notarangelo LD, Rogers MJ, Vezzoni P, Villa A, Frattini A.
    Am J Hum Genet; 2008 Jul; 83(1):64-76. PubMed ID: 18606301
    [Abstract] [Full Text] [Related]

  • 13. Aging increases stromal/osteoblastic cell-induced osteoclastogenesis and alters the osteoclast precursor pool in the mouse.
    Cao JJ, Wronski TJ, Iwaniec U, Phleger L, Kurimoto P, Boudignon B, Halloran BP.
    J Bone Miner Res; 2005 Sep; 20(9):1659-68. PubMed ID: 16059637
    [Abstract] [Full Text] [Related]

  • 14. Autocrine and paracrine nitric oxide regulate attachment of human osteoclasts.
    Yaroslavskiy BB, Li Y, Ferguson DJ, Kalla SE, Oakley JI, Blair HC.
    J Cell Biochem; 2004 Apr 01; 91(5):962-72. PubMed ID: 15034931
    [Abstract] [Full Text] [Related]

  • 15. Osteopetrosis with micro-lacunar resorption because of defective integrin organization.
    Blair HC, Yaroslavskiy BB, Robinson LJ, Mapara MY, Pangrazio A, Guo L, Chen K, Vezzoni P, Tolar J, Orchard PJ.
    Lab Invest; 2009 Sep 01; 89(9):1007-17. PubMed ID: 19546854
    [Abstract] [Full Text] [Related]

  • 16. Analysis of variation in expression of autosomal dominant osteopetrosis type 2: searching for modifier genes.
    Chu K, Koller DL, Snyder R, Fishburn T, Lai D, Waguespack SG, Foroud T, Econs MJ.
    Bone; 2005 Nov 01; 37(5):655-61. PubMed ID: 16120485
    [Abstract] [Full Text] [Related]

  • 17. MCP-1-induced human osteoclast-like cells are tartrate-resistant acid phosphatase, NFATc1, and calcitonin receptor-positive but require receptor activator of NFkappaB ligand for bone resorption.
    Kim MS, Day CJ, Selinger CI, Magno CL, Stephens SR, Morrison NA.
    J Biol Chem; 2006 Jan 13; 281(2):1274-85. PubMed ID: 16280328
    [Abstract] [Full Text] [Related]

  • 18. Osteoclast differentiation from circulating mononuclear precursors in Paget's disease is hypersensitive to 1,25-dihydroxyvitamin D(3) and RANKL.
    Neale SD, Smith R, Wass JA, Athanasou NA.
    Bone; 2000 Sep 13; 27(3):409-16. PubMed ID: 10962353
    [Abstract] [Full Text] [Related]

  • 19. The mouse osteopetrotic grey-lethal mutation induces a defect in osteoclast maturation/function.
    Rajapurohitam V, Chalhoub N, Benachenhou N, Neff L, Baron R, Vacher J.
    Bone; 2001 May 13; 28(5):513-23. PubMed ID: 11344051
    [Abstract] [Full Text] [Related]

  • 20. Acidification of the osteoclastic resorption compartment provides insight into the coupling of bone formation to bone resorption.
    Karsdal MA, Henriksen K, Sørensen MG, Gram J, Schaller S, Dziegiel MH, Heegaard AM, Christophersen P, Martin TJ, Christiansen C, Bollerslev J.
    Am J Pathol; 2005 Feb 13; 166(2):467-76. PubMed ID: 15681830
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.